The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. The Winter Imagine Forum Recap January 28, 2022 Signant Health Posted in Events For Signant Health’s second Imagine Forum, we focused on how the industry can leverage direct-to-patient (DtP) clinical supply approaches to… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More Clinical Data Fraud: Detection & Mitigation Strategies January 5, 2022 Bill Byrom Posted in eCOA One of the most compelling arguments for using electronic data capture methods for patient-reported outcome assessments (ePRO) is the ability to ensure and demonstrate data integrity. Electronic data collection allows study teams to use… Read More Webinar Recap: Applying Advanced Analytics to Overcome CNS Trial Challenges December 20, 2021 Signant Health Posted in Data Analytics If you missed Signant’s webinar on applying analytics to CNS clinical trials, you’re in luck – we’ve summarized the key… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Selecting and Monitoring Clinically Meaningful Data Quality Indicators December 13, 2021 Alan Kott Posted in Data Analytics The ongoing, accelerated digital transformation of clinical trials presents new opportunities for medical research sponsors and clinical research organizations. Increasing… Read More Building Blocks of Efficient IMP Supply and Distribution Strategies December 13, 2021 Signant Health Posted in Clinical Supplies In an era of constant growth in the scale and complexity of clinical trials, planning properly for efficient manufacturing and… Read More Get to Know the SME: Danielle Middleton December 3, 2021 Signant Health Posted in Scientific Advisory We sat down with Signant Health’s newest addition to our in-house team of experts, Dr. Danielle Middleton. Danielle leverages her… Read More Hybrid Trials: Supporting Remote Consent November 19, 2021 Signant Health Posted in eConsent Informed consent is one of the most complex processes within clinical operations. Explaining the highly technical and specialized material so that all participants fully… Read More CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More Previous 1 2 3 4 5 6 Next
The Winter Imagine Forum Recap January 28, 2022 Signant Health Posted in Events For Signant Health’s second Imagine Forum, we focused on how the industry can leverage direct-to-patient (DtP) clinical supply approaches to… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More Clinical Data Fraud: Detection & Mitigation Strategies January 5, 2022 Bill Byrom Posted in eCOA One of the most compelling arguments for using electronic data capture methods for patient-reported outcome assessments (ePRO) is the ability to ensure and demonstrate data integrity. Electronic data collection allows study teams to use… Read More Webinar Recap: Applying Advanced Analytics to Overcome CNS Trial Challenges December 20, 2021 Signant Health Posted in Data Analytics If you missed Signant’s webinar on applying analytics to CNS clinical trials, you’re in luck – we’ve summarized the key… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Selecting and Monitoring Clinically Meaningful Data Quality Indicators December 13, 2021 Alan Kott Posted in Data Analytics The ongoing, accelerated digital transformation of clinical trials presents new opportunities for medical research sponsors and clinical research organizations. Increasing… Read More Building Blocks of Efficient IMP Supply and Distribution Strategies December 13, 2021 Signant Health Posted in Clinical Supplies In an era of constant growth in the scale and complexity of clinical trials, planning properly for efficient manufacturing and… Read More Get to Know the SME: Danielle Middleton December 3, 2021 Signant Health Posted in Scientific Advisory We sat down with Signant Health’s newest addition to our in-house team of experts, Dr. Danielle Middleton. Danielle leverages her… Read More Hybrid Trials: Supporting Remote Consent November 19, 2021 Signant Health Posted in eConsent Informed consent is one of the most complex processes within clinical operations. Explaining the highly technical and specialized material so that all participants fully… Read More CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More Previous 1 2 3 4 5 6 Next